Interaction of C1q with the receptor calreticulin requires a conformational change in C1q

Scandinavian Journal of Immunology

Volumn 59, Issue 5, 2004, Pages 485-495

  Steino A ^a   Jorgensen C S ^a   Laursen, I ^a   Houen, G ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; CALRETICULIN; COLLAGEN TYPE 5; COMPLEMENT COMPONENT C1Q; GUANIDINE; IMMUNOGLOBULIN; OVALBUMIN; PROTEINASE K; SODIUM CHLORIDE; UREA;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; HEAT TREATMENT; HYDROPHOBICITY; MOLECULAR DYNAMICS; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CALRETICULIN; COMPLEMENT C1Q; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MANNOSE-BINDING LECTIN; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 2642510766     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01425.x     Document Type: Article

References (65)

1. Holmskov UL. Collectins and collectin receptors in innate immunity. APMIS Suppl 2000;100:1-59.
2. Botto M, Walport MJ. C1q, autoimmunity and apoptosis. Immunobiology 2002;205:395-406.
3. Arlaud GJ, Gaboriaud C, Thielens NM, Rossi V. Structural biology of C1. Biochem Soc Trans 2002;30:1001-6.
4. Golan MD, Burger R, Loos M. Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies. J Immunol 1982;129:445-7.
5. Gaboriaud C, Juanhuix J, Gruez A et al. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem 2003;278:46974-82.
6. Ghiran I, Tyagi SR, Klickstein LB, Nicholson-Weller A. Expression and function of C1q receptors and C1q binding proteins at the cell surface. Immunobiology 2002;205:407-20.
7. Kishore U, Sontheimer RD, Sastry KN et al. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes. Clin Exp Immunol 1997;108:181-90.
8. Luo X, Weber GA, Zheng J, Gendelman HE, Ikezu T. C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease. J Neuroimmunol 2003;135:62-71.
9. Stuart GR, Lynch NJ, Day AJ, Schwaeble WJ, Sim RB. The C1q and collectin binding site within C1q receptor (cell surface calreticulin). Immunopharmacology 1997;38:73-80.
10. Turner MW. Mannose-binding lectin (MBL) in health and disease. Immunobiology 1998;199:327-39.
11. Drickamer K, Dordal MS, Reynolds L. Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. Complete primary structures and homology with pulmonary surfactant apoprotein. J Biol Chem 1986;261:6878-87.
12. Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001;38:133-49.
13. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996;17:532-40.
14. Weis WI, Taylor ME, Drickamer K. The C-type lectin superfamily in the immune system. Immunol Rev 1998;163:19-34.
15. Chen CB, Wallis R. Stoichiometry of complexes between mannose-binding protein and its associated serine proteases. Defining functional units for complement activation. J Biol Chem 2001;276:25894-902.
16. Dahl MR, Thiel S, Matsushita M et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 2001;15:127-35.
17. Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 2000;165:2637-42.
18. Thielens NM, Cseh S, Thiel S et al. Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J Immunol 2001;166:5068-77.
19. Ogden CA, de Cathelineau A, Hoffmann PR et al. Clq and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001;194:781-95.
20. Vandivier RW, Ogden CA, Fadok VA et al. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol 2002;169:3978-86.
21. Ellgaard L, Riek R, Herrmann T et al. NMR structure of the calreticulin P-domain. Proc Natl Acad Sci USA 2001;98:3133-8.
22. Ellgaard L, Bettendorff P, Braun D et al. NMR structures of 36 and 73-residue fragments of the calreticulin P-domain. J Mol Biol 2002;322:773-84.
23. Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M. Calreticulin: one protein, one gene, many functions. Biochem J 1999;344:281-92.
24. Schrag JD, Bergeron JJ, Li Y et al. The Structure of calnexin, an ER chaperone involved in quality control of protein folding. Mol Cell 2001;8:633-44.
25. Michalak M, Milner RE, Burns K, Opas M. Calreticulin. Biochem J 1992;285:681-92.
26. Milner RE, Baksh S, Shemanko C et al. Calreticulin, and not calsequestrin, is the major calcium binding protein of smooth muscle sarcoplasmic reticulum and liver endoplasmic reticulum. J Biol Chem 1991;266:7155-65.
27. Smith MJ, Koch GL. Multiple zones in the sequence of calreticulin (CRP55, calregulin, HACBP), a major calcium binding ER/SR protein. EMBOJ 1989;8:3581-6.
28. Arosa FA, de Jesus O, Porto G, Carmo AM, de Sousa M. Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex class I molecules. J Biol Chem 1999;274:16917-22.
29. Eggleton P, Lieu TS, Zappi EG et al. Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. Clin Immunol Immunopathol 1994;72:405-9.
30. Eggleton P, Ghebrehiwet B, Coburn JP, Sastry KN, Zaner KS, Tauber AI. Characterization of the human neutrophil C1q receptor and functional effects of free ligand on activated neutrophils. Blood 1994;84:1640-9.
31. Kishore U, Sontheimer RD, Sastry KN et al. Release of calreticulin ftom neutrophils may alter C1q-mediated immune functions. Biochem J 1997;322:543-50.
32. Zhu Q, Zelinka P, White T, Tanzer ML. Calreticulin-integrin bidirectional signaling complex. Biochem Biophys Res Commun 1997;232:354-8.
33. +-binding protein calreticulin and perform, a component of the cytotoxic T-cell granules. Biochemistry 1998;37:10386-94.
34. Coppolino MG, Woodside MJ, Demaurex N, Grinstein S, St Arnaud R, Dedhar S. Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion. Nature 1997;386:843-7.
35. Dedhar S, Rennie PS, Shago M et al. Inhibition of nuclear hormone receptor activity by calreticulin. Nature 1994;367:480-3.
36. Holaska JM, Black BE, Love DC, Hanover JA, Leszyk J, Paschal BM. Calreticulin is a receptor for nuclear export. J Cell Biol 2001;152:127-40.
37. Pike SE, Yao L, Jones KD et al. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med 1998;188:2349-56.
38. Pike SE, Yao L, Setsuda J et al. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 1999;94:2461-8.
39. Spiro RG, Zhu Q, Bhoyroo V, Soling HD. Definition of the lectin-like properties of the molecular chaperone, calreticulin, and demonstration of its copurification with endomannosidase from rat liver Golgi. J Biol Chem 1996;271:11588-94.
40. Svaerke C, Houen G. Chaperone properties of calreticulin. Acta Chem Scand 1998;52:942-9.
41. Wada I, Imai S, Kai M, Sakane F, Kanoh H. Chaperone function of calreticulin when expressed in the endoplasmic reticulum as the membrane-anchored and soluble forms. J Biol Chem 1995;270:20298-304.
42. McGreal E, Casque P. Structure-function studies of the receptors for complement C1q. Biochem Soc Trans 2002;30:1010-4.
43. Eggleton P, Tenner AJ, Reid KB. C1q receptors. Clin Exp Immunol 2000;120:406-12.
44. Sim RB, Moestrup SK, Stuart GR et al. Interaction of C1q and the collectins with the potential receptors calreticulin (cC1qR/collectin receptor) and megalin. Immunobiology 1998;199:208-24.
45. Ghiran I, Klickstein LB, Nicholson-Wellet A. Calreticulin is at the surface of circulating neutrophils and uses CD59 as an adaptor molecule. J Biol Chem 2003;278:21024-31.
46. Basu S, Binder RJ, Ramalingam T, Srivastava PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001;14:303-13.
47. Kovacs H, Campbell ID, Strong P et al. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motife present in the autoantigen calreticulin and interferes with complement activation. Biochemistry 1998;37:17865-74.
48. Stuart GR, Lynch NJ, Lu J et al. Localisation of the C1q binding site within C1q receptor/calreticulin. FEBS Lett 1996;397:245-9.
49. Malhotra R. Collectin receptor (C1q receptor): structure and function. Behring Inst Mitt 1993;93:254-61.
50. Day AJ, Barlow PN, Steinkasserer A, Campbell ID, Sim RB. Progress in determining module structures in C1r and C1s. Behring Inst Mitt 1993;93:31-40.
51. Laursen I. Mannan-binding lectin (MBL) production from human plasma. Biochem Soc Trans 2003;31:758-62.
52. Houen G, Koch C. Human placental calreticulin: purification, characterization and association with other proteins. Acta Chem Scand 1994;48:905-11.
53. Sorensen BK, Hojrup P, Ostergard E et al. Silver staining of proteins on electroblotting membranes and intensification of silver staining of proteins separated by polyacrylamide gel electrophoresis. Anal Biochem 2002;304:33-41.
54. Tschopp J. Kinetics of activation of the first component of complement (C1) by IgG oligomers. Mol Immunol 1982;19:651-7.
55. Vandenberg RJ, Easterbrook-Smith SB, Conformational changes in C1q upon binding to IgG oligomers. FEBS Lett 1986;207:276-9.
56. Fliegel L, Burns K, MacLennan DH, Reithmeier RA, Michalak M. Molecular cloning of the high affinity calcium-binding protein (calreticulin) of skeletal muscle sarcoplasmic reticulum. J Biol Chem 1989;264:21522-8.
57. Fasman GD. Handbook of Biochemistry and Molecular Biology, Proteins. 3rd edn. Cleveland: CRC Press, 1977.
58. Liberti PA, Paul SM. Gross conformation of C1q: a subcomponent of the first component of complement. Biochemistry 1978;17:1952-8.
59. Butler JE. Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays. Methods 2000;22:4-23.
60. Houen G, Koch C. A non-denaturing enzyme linked immunosorbent assay with protein preadsorbed onto aluminum hydroxide. J Immunol Methods 1997;200:99-105.
61. Joergensen CS, Ryder LR, Steinoe A et al. Dimerisation and oligomerisation of the chaperone calreticulin. Eur J Biochem 2003;270:4140-8.
62. Lynch NJ, Schneider H, Sim RB, Bickel U, Schwaeble WJ. In vivo pharmacokinetics of calreticulin S-domain, an inhibitor of the classical complement pathway. Int Immunopharmacol 2002;2:415-22.
63. Zahedi K. Characterization of the binding of serum amyloid P to type IV collagen. J Biol Chem 1996;271:14897-902.
64. Malhotta R, Thiel S, Reid KB, Sim RB. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med 1990;172:955-9.
65. Leach MR, Cohen-Doyle MF, Thomas DY, Williams DB. Localization of the lectin, ERp57 binding, and polypeptide binding sites of calnexin and calreticulin. J Biol Chem 2002;277:29686-97.